Clinical Studies for Children and Adolescents with Autism Spectrum Disorder, Pervasive Developmental Disorder (PDD), and other disorders
Our list of clinical studies provides contact information and links to basic participation requirements.
Please check this page frequently. New studies will be posted prior to subject recruiting.
Autism/PDD Studies || Completed Studies || Other Studies
Study of Risperidone in Children and Adolescents with Autism
Click Here for a Printable Flyer
The Ohio State University is accepting children and adolescents with autistic disorder ages 5-17 for a research study of risperidone for irritability, aggression, or self-injury associated with Autistic Disorder. Evaluation and treatment are free of charge. Some reimbursement for travel and time provided. Risks and benefits explained prior to participation.
For more information without obligation, please contact Ashley Reno, study coordinator, at (614) 688-8214 or reno.37@osu.edu |
Study of Mecamylamine: A Possible New Treatment for Autism
Click Here for a Printable Flyer
For more information, please contact Bethany Bates, Study Coordinator, at 614-292-3698 or bates.226@osu.edu. |
Study of an Investigational Medication with Autistic Disorder
Click Here for a Printable Flyer
For more information, please contact Lauren Pinto, Study Coordinator, at 614-688-3848 or lauren.pinto@osumc.edu. |
Research in Sleep Disturbance Associated with Pervasive Developmental Disorder
Researchers at The Ohio State University's Nisonger Center are testing the effects of melatonin supplementation in children with autism spectrum disorders and sleep disturbance.
Click Here for a Printable Flyer
For more information, please contact Jill Hollway at 614-247-6402 or hollway.3@osu.edu. |
|
Research in Serious Behavioral Problems Associated With Autistic Disorder
For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu.
|
Study of Risperidone (Risperdal) and Behavioral Therapy in Children with Pervasive Developmental Disorders
For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu. |
Study of a Medication for Gastrointestinal Problems in Autistic Children
For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu. |
Study of the Pharmacokinetic Parameters of Risperidone in Patients with Autism Spectrum Disorders and Tourette Syndrome
Ages 4 - 21
For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu. |
Risperidone on Cognitive Motor Performance and Motor Movements in Children with Disruptive Behavior Disorders
For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu. |
Pharmacogenetics of Risperidone in Children with PDD, Ages 4 -21 (Adults eligible)
For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu. |
A Study of Atomoxetine (Strattera™) for Children and Adolescents with Autism, Asperger's Syndrome, or other Pervasive Developmental Disorder (PDD) and Signs of Attention-Deficit/Hyperactivity Disorder (ADHD)
For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu. |
Ritalin® Treatment or Guanfacine for Hyperactivity/Impulsiveness in Children with Pervasive Developmental Disorders
For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu. |
Measurement of Risperidone and 9-hydroxyrisperidone in Saliva and Plasma
For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu.
|
***Check back frequently for updates***
^Back to top
|
|
